Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

NCT06234605

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View all 20 locations
View Trial Details
Recruiting

Safety and Early Signs of Efficacy of IL12-L19L19.

NCT04471987

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Universitaetsklinik Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Universitätsklinikum Heidelberg, Nationalen Centrum für Tumorerkrankungen (NCT), Dermatoonkologie Heidelberg, Germany
  • Universitätsklinikum Leipzig, Klinik für Dermatologie, Venerologie und Allergologie Leipzig, Germany
  • Universitätsklinikum Tübingen, Klinik für Innere Medizin VIII Medizinische Onkologie und Pneumologie Tübingen, Germany
View Trial Details
Recruiting

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

NCT05717166

Conditions
Metastatic Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • BC Cancer - Centre for the North Prince George, British Columbia, Canada
  • BC Cancer - Vancouver Vancouver, British Columbia, Canada
  • London Regional Cancer Program of the Lawson Health Research Institute London, Ontario, Canada
  • Centre Hospitalier de l'Université de Montréal-CHUM Montreal, Quebec, Canada
View Trial Details
Recruiting

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

NCT06527027

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Lymph Node Metastasis, +10 more
Locations
  • Maria Skłodowska-Curie National Research Institute of Oncology - National Research Institute Krakow, Poland
  • Copernicus Memorial Hospital Lodz, Poland
  • Independent Public Healthcare Centre (SPZOZ) , University Clinical Hospital No. 2 of the Medical University of Łódź Lodz, Poland
  • Doradztwo i Zarządzanie w Opiece Zdrowotnej A.K. Sp.z o.o Warsaw, Poland
View Trial Details

Related conditions